Don't rely solely on ELISAs for HCP evaluation in process development
- the 3 reasons why mass spectrometry assays provide better HCP impurity control
I will show the danger of relying solely on ELISA assays for HCP evaluation
(this is the most important reason why so many of our customers use our LC-MS based Host Cell Protein analysis for process development).
You will get examples of how an LC-MS based HCP assay evaluates the difference between batches
– and provides information on which parameters that give specific results.
Bonus: We will go over customer cases
showing how an LC-MS assay was used for documenting the clearance of HCPs during a 6-step purification process, and how info about specific HCPs was used for targeted optimization of the process.
Nec nam aliquam sem et
Cras semper auctor neque vitae tempus. Adipiscing diam donec adipiscing tristique. Vitae et leo duis ut diam.